nodes	percent_of_prediction	percent_of_DWPC	metapath
Methamphetamine—Erectile dysfunction—Propantheline—pancreatitis	0.0286	0.109	CcSEcCtD
Methamphetamine—Palpitations—Propantheline—pancreatitis	0.0191	0.0728	CcSEcCtD
Methamphetamine—Psychotic disorder—Hyoscyamine—pancreatitis	0.018	0.0684	CcSEcCtD
Methamphetamine—Tachycardia—Propantheline—pancreatitis	0.0173	0.0656	CcSEcCtD
Methamphetamine—Insomnia—Propantheline—pancreatitis	0.016	0.0608	CcSEcCtD
Methamphetamine—Aspartame—TRPV1—pancreatitis	0.0153	0.487	CrCbGaD
Methamphetamine—Constipation—Propantheline—pancreatitis	0.0151	0.0575	CcSEcCtD
Methamphetamine—Erectile dysfunction—Hyoscyamine—pancreatitis	0.0147	0.0557	CcSEcCtD
Methamphetamine—Urticaria—Propantheline—pancreatitis	0.014	0.0534	CcSEcCtD
Methamphetamine—Hypersensitivity—Propantheline—pancreatitis	0.013	0.0495	CcSEcCtD
Methamphetamine—Dizziness—Propantheline—pancreatitis	0.0117	0.0444	CcSEcCtD
Methamphetamine—Headache—Propantheline—pancreatitis	0.0111	0.0421	CcSEcCtD
Methamphetamine—Agitation—Hyoscyamine—pancreatitis	0.0102	0.0387	CcSEcCtD
Methamphetamine—Palpitations—Hyoscyamine—pancreatitis	0.0098	0.0373	CcSEcCtD
Methamphetamine—Tachycardia—Hyoscyamine—pancreatitis	0.00883	0.0336	CcSEcCtD
Methamphetamine—Benzyl alcohol—ALDH2—pancreatitis	0.00867	0.276	CrCbGaD
Methamphetamine—Insomnia—Hyoscyamine—pancreatitis	0.00818	0.0311	CcSEcCtD
Methamphetamine—Dyspepsia—Hyoscyamine—pancreatitis	0.00797	0.0303	CcSEcCtD
Methamphetamine—Constipation—Hyoscyamine—pancreatitis	0.00774	0.0294	CcSEcCtD
Methamphetamine—Urticaria—Hyoscyamine—pancreatitis	0.00719	0.0273	CcSEcCtD
Methamphetamine—Hypersensitivity—Hyoscyamine—pancreatitis	0.00667	0.0254	CcSEcCtD
Methamphetamine—Diarrhoea—Hyoscyamine—pancreatitis	0.00619	0.0235	CcSEcCtD
Methamphetamine—Dizziness—Hyoscyamine—pancreatitis	0.00598	0.0228	CcSEcCtD
Methamphetamine—Headache—Hyoscyamine—pancreatitis	0.00567	0.0216	CcSEcCtD
Methamphetamine—Pseudoephedrine—TNF—pancreatitis	0.00318	0.101	CrCbGaD
Methamphetamine—Nateglinide—PPARG—pancreatitis	0.00312	0.0993	CrCbGaD
Methamphetamine—Nateglinide—ALB—pancreatitis	0.00117	0.0374	CrCbGaD
Methamphetamine—MAOB—Metabolism—LPL—pancreatitis	0.000221	0.000313	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—GCG—pancreatitis	0.00022	0.000312	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmission across Chemical Synapses—HRAS—pancreatitis	0.000218	0.000309	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—KNG1—pancreatitis	0.000217	0.000308	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PLA2G1B—pancreatitis	0.000217	0.000307	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—BDKRB2—pancreatitis	0.000217	0.000307	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CNR1—pancreatitis	0.000213	0.000301	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—KNG1—pancreatitis	0.000211	0.000299	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—A2M—pancreatitis	0.000209	0.000297	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—FDX1—pancreatitis	0.000208	0.000294	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—CXCL8—pancreatitis	0.000206	0.000292	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—SST—pancreatitis	0.000206	0.000292	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—GCG—pancreatitis	0.000205	0.000291	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—HRAS—pancreatitis	0.000205	0.000291	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PTHLH—pancreatitis	0.000205	0.00029	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—SMO—pancreatitis	0.000205	0.00029	CbGpPWpGaD
Methamphetamine—SLC6A2—Transmembrane transport of small molecules—ALB—pancreatitis	0.000204	0.000289	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—SCT—pancreatitis	0.000202	0.000286	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—FGG—pancreatitis	0.000202	0.000286	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CASR—pancreatitis	0.000202	0.000286	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PPY—pancreatitis	0.000198	0.000281	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CX3CL1—pancreatitis	0.000198	0.00028	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—CASP3—pancreatitis	0.000198	0.00028	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—ALB—pancreatitis	0.000197	0.00028	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—KNG1—pancreatitis	0.000197	0.000279	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—IL6—pancreatitis	0.000196	0.000278	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PPP3CA—pancreatitis	0.000195	0.000277	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—CCL5—pancreatitis	0.000194	0.000275	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—BDKRB2—pancreatitis	0.000194	0.000275	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ADH4—pancreatitis	0.000193	0.000273	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MTNR1B—pancreatitis	0.000192	0.000273	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CCK—pancreatitis	0.000192	0.000273	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—ALDH2—pancreatitis	0.000191	0.000271	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—CNR1—pancreatitis	0.00019	0.00027	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—FGG—pancreatitis	0.000188	0.000267	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SCT—pancreatitis	0.000188	0.000267	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CASR—pancreatitis	0.000188	0.000267	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CNR2—pancreatitis	0.000187	0.000266	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—A2M—pancreatitis	0.000187	0.000266	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TACR1—pancreatitis	0.000187	0.000266	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—CXCL8—pancreatitis	0.000187	0.000265	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—SST—pancreatitis	0.000187	0.000265	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—LPL—pancreatitis	0.000187	0.000265	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatitis	0.000187	0.000264	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CX3CL1—pancreatitis	0.000185	0.000262	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—ALB—pancreatitis	0.000184	0.000261	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CCKAR—pancreatitis	0.000184	0.000261	CbGpPWpGaD
Methamphetamine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—pancreatitis	0.000184	0.00026	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—GCG—pancreatitis	0.000184	0.00026	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—CCL5—pancreatitis	0.000182	0.000257	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PRSS1—pancreatitis	0.000181	0.000257	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmembrane transport of small molecules—ALB—pancreatitis	0.00018	0.000256	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—CCL2—pancreatitis	0.00018	0.000255	CbGpPWpGaD
Methamphetamine—MAOA—Neuronal System—HRAS—pancreatitis	0.00018	0.000255	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CCK—pancreatitis	0.00018	0.000255	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MTNR1B—pancreatitis	0.00018	0.000255	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—CCL5—pancreatitis	0.000176	0.00025	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—GCG—pancreatitis	0.000176	0.00025	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—KNG1—pancreatitis	0.000176	0.00025	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PLA2G1B—pancreatitis	0.000176	0.00025	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—BDKRB2—pancreatitis	0.000176	0.000249	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TACR1—pancreatitis	0.000175	0.000248	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CNR2—pancreatitis	0.000175	0.000248	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—A2M—pancreatitis	0.000175	0.000248	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—CXCL8—pancreatitis	0.000175	0.000248	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CNR1—pancreatitis	0.000173	0.000245	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CCKAR—pancreatitis	0.000172	0.000244	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PRSS3—pancreatitis	0.000172	0.000244	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PNLIP—pancreatitis	0.000172	0.000244	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—FGA—pancreatitis	0.000171	0.000243	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—HTR2A—pancreatitis	0.000171	0.000243	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—A2M—pancreatitis	0.00017	0.000241	CbGpPWpGaD
Methamphetamine—SLC6A3—Neuronal System—HRAS—pancreatitis	0.000167	0.000237	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—GCG—pancreatitis	0.000167	0.000236	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—NRAS—pancreatitis	0.000166	0.000235	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CCL5—pancreatitis	0.000165	0.000234	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—PPARG—pancreatitis	0.000161	0.000228	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—KNG1—pancreatitis	0.00016	0.000227	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—FGA—pancreatitis	0.00016	0.000227	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—HTR2A—pancreatitis	0.00016	0.000227	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PTHLH—pancreatitis	0.000159	0.000226	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—SMO—pancreatitis	0.000159	0.000226	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—INS—pancreatitis	0.000158	0.000224	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—FGB—pancreatitis	0.000156	0.000221	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—HTR2A—pancreatitis	0.000156	0.000221	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—ALDH2—pancreatitis	0.000156	0.00022	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—XDH—pancreatitis	0.000154	0.000219	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—TGFB1—pancreatitis	0.000154	0.000218	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—FGG—pancreatitis	0.000153	0.000217	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SCT—pancreatitis	0.000153	0.000217	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CASR—pancreatitis	0.000153	0.000217	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PPP3CA—pancreatitis	0.000152	0.000215	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CX3CL1—pancreatitis	0.00015	0.000213	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—ALB—pancreatitis	0.00015	0.000212	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PTHLH—pancreatitis	0.000149	0.000211	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SMO—pancreatitis	0.000149	0.000211	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—CCL5—pancreatitis	0.000147	0.000209	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MTNR1B—pancreatitis	0.000146	0.000207	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCK—pancreatitis	0.000146	0.000207	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—SST—pancreatitis	0.000146	0.000207	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—FGB—pancreatitis	0.000146	0.000206	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—HTR2A—pancreatitis	0.000145	0.000206	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—GCG—pancreatitis	0.000145	0.000206	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—ALB—pancreatitis	0.000145	0.000205	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—DUSP6—pancreatitis	0.000144	0.000205	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ADH1B—pancreatitis	0.000144	0.000204	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—KRAS—pancreatitis	0.000142	0.000202	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—A2M—pancreatitis	0.000142	0.000202	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CNR2—pancreatitis	0.000142	0.000202	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TACR1—pancreatitis	0.000142	0.000202	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—CXCL8—pancreatitis	0.000142	0.000201	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PPP3CA—pancreatitis	0.000142	0.000201	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCKAR—pancreatitis	0.00014	0.000198	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—LPL—pancreatitis	0.000138	0.000196	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—BDKRB2—pancreatitis	0.000137	0.000194	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PPARG—pancreatitis	0.000136	0.000193	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SST—pancreatitis	0.000136	0.000193	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—DUSP6—pancreatitis	0.000135	0.000191	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CNR1—pancreatitis	0.000135	0.000191	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—NRAS—pancreatitis	0.000134	0.00019	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CCL5—pancreatitis	0.000134	0.00019	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—INS—pancreatitis	0.000134	0.000189	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—FGA—pancreatitis	0.00013	0.000184	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—HTR2A—pancreatitis	0.00013	0.000184	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—GCG—pancreatitis	0.00013	0.000184	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—BDKRB2—pancreatitis	0.000128	0.000181	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—PTGS2—pancreatitis	0.000127	0.00018	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CNR1—pancreatitis	0.000126	0.000178	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—NRAS—pancreatitis	0.000126	0.000178	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—TGFB1—pancreatitis	0.000125	0.000177	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—KNG1—pancreatitis	0.000125	0.000177	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—ALB—pancreatitis	0.000123	0.000174	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—CCL2—pancreatitis	0.000122	0.000172	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—GCG—pancreatitis	0.000121	0.000172	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—HRAS—pancreatitis	0.000121	0.000172	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PTHLH—pancreatitis	0.000121	0.000171	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SMO—pancreatitis	0.000121	0.000171	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—FGB—pancreatitis	0.000118	0.000168	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—HTR2A—pancreatitis	0.000118	0.000167	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—GCG—pancreatitis	0.000118	0.000167	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—TGFB1—pancreatitis	0.000117	0.000165	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—KNG1—pancreatitis	0.000116	0.000165	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—IL6—pancreatitis	0.000116	0.000164	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—KRAS—pancreatitis	0.000116	0.000164	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PPP3CA—pancreatitis	0.000115	0.000163	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PLA2G1B—pancreatitis	0.000115	0.000163	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PDGFA—pancreatitis	0.000115	0.000162	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—LPL—pancreatitis	0.000114	0.000161	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CCL2—pancreatitis	0.000114	0.000161	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—A2M—pancreatitis	0.000111	0.000157	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SST—pancreatitis	0.000111	0.000157	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—DUSP6—pancreatitis	0.00011	0.000155	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—KRAS—pancreatitis	0.000108	0.000153	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PTGS2—pancreatitis	0.000107	0.000152	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PDGFA—pancreatitis	0.000107	0.000152	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—CXCL8—pancreatitis	0.000106	0.00015	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CCL5—pancreatitis	0.000104	0.000148	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—BDKRB2—pancreatitis	0.000104	0.000147	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CNR1—pancreatitis	0.000102	0.000145	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—NRAS—pancreatitis	0.000102	0.000144	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—LPL—pancreatitis	0.000102	0.000144	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ALDH2—pancreatitis	0.000101	0.000144	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PPARG—pancreatitis	0.000101	0.000143	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—INS—pancreatitis	9.91e-05	0.000141	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—CXCL8—pancreatitis	9.89e-05	0.00014	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—GCG—pancreatitis	9.86e-05	0.00014	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—HRAS—pancreatitis	9.83e-05	0.000139	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CCL5—pancreatitis	9.74e-05	0.000138	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—SPP1—pancreatitis	9.65e-05	0.000137	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—CXCL8—pancreatitis	9.61e-05	0.000136	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—LPL—pancreatitis	9.52e-05	0.000135	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—TGFB1—pancreatitis	9.47e-05	0.000134	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—KNG1—pancreatitis	9.46e-05	0.000134	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—LPL—pancreatitis	9.25e-05	0.000131	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CCL2—pancreatitis	9.22e-05	0.000131	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HTR2A—pancreatitis	9.19e-05	0.00013	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—HRAS—pancreatitis	9.18e-05	0.00013	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—ALB—pancreatitis	9.09e-05	0.000129	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SPP1—pancreatitis	9.02e-05	0.000128	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CXCL8—pancreatitis	8.98e-05	0.000127	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—KRAS—pancreatitis	8.77e-05	0.000124	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PDGFA—pancreatitis	8.7e-05	0.000123	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HTR2A—pancreatitis	8.58e-05	0.000122	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—LEP—pancreatitis	8.54e-05	0.000121	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PPARG—pancreatitis	8.31e-05	0.000118	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—INS—pancreatitis	8.15e-05	0.000116	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—CXCL8—pancreatitis	8.03e-05	0.000114	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—LEP—pancreatitis	7.98e-05	0.000113	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PTGS2—pancreatitis	7.95e-05	0.000113	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCL5—pancreatitis	7.91e-05	0.000112	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—LPL—pancreatitis	7.73e-05	0.00011	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—NRAS—pancreatitis	7.71e-05	0.000109	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GCG—pancreatitis	7.68e-05	0.000109	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—ALB—pancreatitis	7.48e-05	0.000106	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—HRAS—pancreatitis	7.46e-05	0.000106	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SPP1—pancreatitis	7.32e-05	0.000104	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—INS—pancreatitis	7.3e-05	0.000103	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CXCL8—pancreatitis	7.29e-05	0.000103	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—NRAS—pancreatitis	7.2e-05	0.000102	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CCL2—pancreatitis	7.18e-05	0.000102	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HTR2A—pancreatitis	6.97e-05	9.88e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—INS—pancreatitis	6.82e-05	9.66e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PPARG—pancreatitis	6.75e-05	9.57e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CCL2—pancreatitis	6.71e-05	9.51e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—KRAS—pancreatitis	6.64e-05	9.41e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—INS—pancreatitis	6.62e-05	9.39e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PTGS2—pancreatitis	6.54e-05	9.27e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—LEP—pancreatitis	6.48e-05	9.19e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—KRAS—pancreatitis	6.2e-05	8.79e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MDM2—pancreatitis	6.07e-05	8.61e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—ALB—pancreatitis	6.07e-05	8.61e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—LPL—pancreatitis	6.03e-05	8.54e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—NRAS—pancreatitis	5.85e-05	8.29e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CXCL8—pancreatitis	5.68e-05	8.05e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MDM2—pancreatitis	5.67e-05	8.04e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—HRAS—pancreatitis	5.64e-05	8e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—INS—pancreatitis	5.54e-05	7.85e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCL2—pancreatitis	5.45e-05	7.72e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CASP3—pancreatitis	5.43e-05	7.7e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—IL6—pancreatitis	5.4e-05	7.65e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PTGS2—pancreatitis	5.31e-05	7.53e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CXCL8—pancreatitis	5.3e-05	7.52e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—HRAS—pancreatitis	5.27e-05	7.47e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CASP3—pancreatitis	5.08e-05	7.19e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—IL6—pancreatitis	5.04e-05	7.15e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—KRAS—pancreatitis	5.04e-05	7.14e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MDM2—pancreatitis	4.61e-05	6.53e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NRAS—pancreatitis	4.56e-05	6.46e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PPARG—pancreatitis	4.4e-05	6.24e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—INS—pancreatitis	4.32e-05	6.12e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CXCL8—pancreatitis	4.31e-05	6.11e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—HRAS—pancreatitis	4.28e-05	6.07e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NRAS—pancreatitis	4.25e-05	6.03e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TGFB1—pancreatitis	4.23e-05	6e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CASP3—pancreatitis	4.12e-05	5.84e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—IL6—pancreatitis	4.1e-05	5.81e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ALB—pancreatitis	3.96e-05	5.61e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TGFB1—pancreatitis	3.95e-05	5.6e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—KRAS—pancreatitis	3.92e-05	5.56e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—KRAS—pancreatitis	3.66e-05	5.19e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PTGS2—pancreatitis	3.46e-05	4.91e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NRAS—pancreatitis	3.46e-05	4.9e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HRAS—pancreatitis	3.33e-05	4.72e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TGFB1—pancreatitis	3.21e-05	4.55e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL6—pancreatitis	3.19e-05	4.52e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HRAS—pancreatitis	3.11e-05	4.41e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL6—pancreatitis	2.98e-05	4.22e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—KRAS—pancreatitis	2.97e-05	4.22e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HRAS—pancreatitis	2.53e-05	3.58e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL6—pancreatitis	2.42e-05	3.43e-05	CbGpPWpGaD
